Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intrinsic pathway is a crucial part of the coagulation cascade, initiating clot formation in response to internal vascular damage. It involves a series of enzymatic reactions triggered by contact with negatively charged surfaces and ultimately leads to the activation of Factor X and the common pathway. Deficiencies in the pathway's factors can result in bleeding disorders, while excessive activation can contribute to thrombosis.
Inhibition of specific coagulation factors within the intrinsic pathway or the common pathway, ultimately reducing thrombin generation and fibrin formation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intrinsic Pathway of Coagulation.